FBT stock forecast, quote, news & analysis

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exact Sciences Corp (NASDAQ:EXAS), Exelixis (NASDAQ:EXEL), Intra-Cellular Therapies (NASDAQ:ITCI).

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

The average market capitalization across the First Trust NYSE Arca Biotech ETF ETF is 27.09B. The market cap for tickers in the group ranges from 1.62B to 151.69B. AMGN holds the highest valuation in this group at 151.69B. The lowest valued company is DVAX at 1.62B.

The average weekly price growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was -2%. For the same ETF, the average monthly price growth was -3%, and the average quarterly price growth was 10%. NTRA experienced the highest price growth at 12%, while HALO experienced the biggest fall at -15%.

The average weekly volume growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was -27%. For the same stocks of the ETF, the average monthly volume growth was 19% and the average quarterly volume growth was 12%